Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Merck & Company (MRK)

Merck & Company (MRK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 215,942,016
  • Shares Outstanding, K 2,560,375
  • Annual Sales, $ 42,294 M
  • Annual Income, $ 6,220 M
  • 60-Month Beta 0.53
  • Price/Sales 5.07
  • Price/Cash Flow 13.49
  • Price/Book 7.77

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 1.25
  • Number of Estimates 5
  • High Estimate 1.28
  • Low Estimate 1.23
  • Prior Year 1.19
  • Growth Rate Est. (year over year) +5.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
80.54 +4.76%
on 10/02/19
85.87 -1.75%
on 09/20/19
+1.76 (+2.13%)
since 09/13/19
3-Month
78.85 +7.00%
on 09/10/19
87.35 -3.41%
on 08/29/19
+4.64 (+5.82%)
since 07/12/19
52-Week
66.10 +27.64%
on 10/25/18
87.35 -3.41%
on 08/29/19
+14.56 (+20.86%)
since 10/12/18

Most Recent Stories

More News
Watch for Merck & Co to Potentially Pullback After Gaining 1.99% Yesterday

Merck & Co (NYSE:MRK) traded in a range yesterday that spanned from a low of $84.28 to a high of $85.44. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $84.85...

MRK : 84.52 (+0.21%)
Merck & Co Rises 1.99% on Heavy Volume: Watch For Potential Pullback

Merck & Co (NYSE:MRK) traded in a range yesterday that spanned from a low of $84.28 to a high of $85.44. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $84.85...

MRK : 84.52 (+0.21%)
Seattle Genetics Up More Than 20% in 3 Months: Here's Why

Seattle Genetics' (SGEN) only marketed product, Adcetris, has been performing well since its launch. The company's established pipeline candidates are also progressing well.

MRK : 84.52 (+0.21%)
RHHBY : 36.0000 (-0.41%)
SGEN : 82.67 (+0.08%)
EXAS : 92.43 (-0.08%)
4 Stocks From Highest Job-Creating Sectors in September

Apart from the decent number of new jobs, the unemployment rate in the United States dropped 0.2 percentage points to hit a five-decade low of 3.5% last month.

MRK : 84.52 (+0.21%)
CLGX : 46.76 (+0.04%)
MDT : 107.88 (+0.28%)
BAH : 71.27 (-0.29%)
Kaminario Expands Growth Advisory Board With Four New Technology Experts

Kaminario, a leading cloud infrastructure company, today announced it has appointed four experienced technology executives to the company's growth advisory board. This advisory board was created to help...

MRK : 84.52 (+0.21%)
NexTech Appoints New Chief Financial Officer

NexTech AR Solutions (the "Company" or "NexTech") (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29) is pleased to announce that it has appointed Kashif Malik as Chief Financial Officer ("CFO") of the Company.

NEXCF : 0.7399 (+5.82%)
NTAR.CN : 0.930 (+16.25%)
MRK : 84.52 (+0.21%)
REAL.TO : 11.05 (-0.27%)
Global Nasal Drug Delivery Systems Market to Reap Excessive Revenues by 2019-2028

Nasal Drug Delivery Systems Market report 2019 is dispensed after a thorough study of various key market segments like Market Size, Latest Trends, Market Threats & . Nasal Drug Delivery Systems Market...

ATR : 116.37 (+0.03%)
MRK : 84.52 (+0.21%)
NVS : 86.29 (-0.36%)
PFE : 36.12 (+0.03%)
VRX.TO : 30.80 (-3.33%)
Global Glyoxal Market Forecasts to 2024 - Leading Players are BASF, Merck, Thermo Fisher Scientific, WeylChem International, and Haihang Group

The "Glyoxal Market by Application (Crosslinking, Intermediate), End-Use Industry (Textile, Paper, Derivatives, Oil & Gas, Cosmetic/Personal Care, Leather), Region (North America, Europe, APAC, Middle...

MRK : 84.52 (+0.21%)
J&J Ordered by Philadelphia Jury to Pay $8B in Risperdal Case

Philadelphia jury orders J&J (JNJ) to pay punitive damages of $8 billion to a man who claims that the use of Risperdal caused him to develop breasts.

ABBV : 73.61 (-0.03%)
MRK : 84.52 (+0.21%)
SNY : 44.89 (-0.13%)
JNJ : 130.60 (-0.56%)
BriaCell Therapeutics Corp. to File Amendment to Management Information Circular

BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, announces...

BCT.VN : 0.040 (-11.11%)
BCTXF : 0.0365 (+10.61%)
MRK : 84.52 (+0.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade MRK with:

Business Summary

Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies...

See More

Key Turning Points

2nd Resistance Point 85.86
1st Resistance Point 85.10
Last Price 84.52
1st Support Level 83.92
2nd Support Level 83.50

See More

52-Week High 87.35
Last Price 84.52
Fibonacci 61.8% 79.23
Fibonacci 50% 76.72
Fibonacci 38.2% 74.22
52-Week Low 66.10

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar